title: Raltegravir-induced cerebellar ataxia.
authors.forename: Kim A
authors.initials: KA
authors.lastname: Reiss
authors.forename: Justin R
authors.initials: JR
authors.lastname: Bailey
authors.forename: Paul A
authors.initials: PA
authors.lastname: Pham
authors.forename: Joel E
authors.initials: JE
authors.lastname: Gallant
mesh_terms: D002524:Cerebellar Ataxia / Q000139:chemically induced*; D005260:Female; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D015497:HIV-1; D006801:Humans; D008875:Middle Aged; D009570:Nitriles; D011724:Pyridazines / Q000008:administration & dosage*; D011743:Pyrimidines; D011760:Pyrrolidinones / Q000009:adverse effects*; D000068898:Raltegravir Potassium; D016896:Treatment Outcome
chemical_list: D009570:Nitriles; D011724:Pyridazines; D011743:Pyrimidines; D011760:Pyrrolidinones; C451734:etravirine; D000068898:Raltegravir Potassium